Lyme disease

WALL-Y 2 min read

💉 New vaccine reduced Lyme disease cases by 70 percent in clinical trial

Pharmaceutical companies Pfizer and Valneva report that their Lyme disease vaccine LB6V reduced the number of disease cases by around 70 percent compared with placebo. It would become the first approved Lyme disease vaccine for humans in nearly three decades.